Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Stanulla

Showing results (41-50 of 146) with videos related to

Pageof 15
Sort By:
Science Translational Medicine|May 20, 2016
Activation of concurrent apoptosis and necroptosis by SMAC mimetics for the treatment of refractory and relapsed ALLScott McComb, Júlia Aguadé-Gorgorió, Lena Harder, et al.
Pediatric Blood & Cancer|September 22, 2012
Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemiaJana Volejnikova, Ester Mejstrikova, Petra Dörge, et al.
Blood|March 16, 2010
CD11b is a therapy resistance- and minimal residual disease-specific marker in precursor B-cell acute lymphoblastic leukemiaPeter Rhein, Rita Mitlohner, Giuseppe Basso, et al.
Leukemia & Lymphoma|September 2, 2015
Genetic alterations in glucocorticoid signaling pathway components are associated with adverse prognosis in children with relapsed ETV6/RUNX1-positive acute lymphoblastic leukemiaReinhard Grausenburger, Stephan Bastelberger, Cornelia Eckert, et al.
Nature Medicine|October 26, 2006
LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropeniaJulia Skokowa, Gunnar Cario, Murat Uenalan, et al.
Blood|September 25, 2004
Distinct gene expression profiles determine molecular treatment response in childhood acute lymphoblastic leukemiaGunnar Cario, Martin Stanulla, Bernard M Fine, et al.
Genes, Chromosomes & Cancer|March 4, 2008
Copy number alterations in childhood acute lymphoblastic leukemia and their association with minimal residual diseaseDoris Steinemann, Gunnar Cario, Martin Stanulla, et al.
The EMBO Journal|February 22, 2017
Molecular role of the PAX5-ETV6 oncoprotein in promoting B-cell acute lymphoblastic leukemiaLeonie Smeenk, Maria Fischer, Sabine Jurado, et al.
JAMA|March 24, 2005
Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemiaMartin Stanulla, Elke Schaeffeler, Thomas Flohr, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 15, 2015
Evaluation of a pediatric liquid formulation to improve 6-mercaptopurine therapy in childrenAdam de Beaumais Tiphaine, Lisa Lynqsie Hjalgrim, Jacob Nersting, et al.
Pageof 15

Showing results (41-50 of 146) with videos related to

Sort By:
Pageof 15
Science Translational Medicine|May 20, 2016
Activation of concurrent apoptosis and necroptosis by SMAC mimetics for the treatment of refractory and relapsed ALLScott McComb, Júlia Aguadé-Gorgorió, Lena Harder, et al.
Pediatric Blood & Cancer|September 22, 2012
Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemiaJana Volejnikova, Ester Mejstrikova, Petra Dörge, et al.
Blood|March 16, 2010
CD11b is a therapy resistance- and minimal residual disease-specific marker in precursor B-cell acute lymphoblastic leukemiaPeter Rhein, Rita Mitlohner, Giuseppe Basso, et al.
Leukemia & Lymphoma|September 2, 2015
Genetic alterations in glucocorticoid signaling pathway components are associated with adverse prognosis in children with relapsed ETV6/RUNX1-positive acute lymphoblastic leukemiaReinhard Grausenburger, Stephan Bastelberger, Cornelia Eckert, et al.
Nature Medicine|October 26, 2006
LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropeniaJulia Skokowa, Gunnar Cario, Murat Uenalan, et al.
Blood|September 25, 2004
Distinct gene expression profiles determine molecular treatment response in childhood acute lymphoblastic leukemiaGunnar Cario, Martin Stanulla, Bernard M Fine, et al.
Genes, Chromosomes & Cancer|March 4, 2008
Copy number alterations in childhood acute lymphoblastic leukemia and their association with minimal residual diseaseDoris Steinemann, Gunnar Cario, Martin Stanulla, et al.
The EMBO Journal|February 22, 2017
Molecular role of the PAX5-ETV6 oncoprotein in promoting B-cell acute lymphoblastic leukemiaLeonie Smeenk, Maria Fischer, Sabine Jurado, et al.
JAMA|March 24, 2005
Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemiaMartin Stanulla, Elke Schaeffeler, Thomas Flohr, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 15, 2015
Evaluation of a pediatric liquid formulation to improve 6-mercaptopurine therapy in childrenAdam de Beaumais Tiphaine, Lisa Lynqsie Hjalgrim, Jacob Nersting, et al.
Pageof 15